Corpus Intelligence IC Memo — ASCENSION ST. VINCENT EVANSVILLE 2026-04-26 14:09 UTC
IC Memo — ASCENSION ST. VINCENT EVANSVILLE
Investment Committee Memorandum | IN | 346 beds | Grade C | EBITDA uplift $49.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASCENSION ST. VINCENT EVANSVILLE

CCN 150100 | VANDERBURGH, IN | 346 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ASCENSION ST. VINCENT EVANSVILLE is a 346-bed suburban community hospital in VANDERBURGH, IN with $671.8M in net patient revenue and a 11.4% operating margin. The hospital serves a payer mix of 28.4% Medicare, 5.2% Medicaid, and 66.4% commercial.

Thesis: Platform Growth. Our ML models identify $49.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.4% to 18.7% (+736bps).

Net Revenue HCRIS$671.8M
Current EBITDA COMPUTED$76.4M
Operating Margin COMPUTED11.4%
Occupancy HCRIS44.6%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS26.9%
Distress Probability ML49.1%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
24
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 11.4% places it above the state median. Among 24 size-comparable peers (173-692 beds), the median margin is 3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (173-692), prioritizing same-state peers. 24 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASCENSION ST. VINCENT EVANSVIL (Target)IN346$671.8M11.4%
COMMUNITY HEALTH NETWORK INC.IN387$1.24B16.4%
DEACONESS HOSPITALIN545$1.14B0.7%
FRANCISCAN HEALTH INDIANAPOLISIN401$891.4M-0.3%
MEMORIAL HOSPITAL OF SOUTH BENIN429$631.5M9.7%
COMMUNITY HOSPITALIN405$615.1M6.0%
UNION HOSPITAL INC.IN258$581.9M3.8%
LUTHERAN HOSPITAL OF INDIANAIN335$580.1M3.8%
COMMUNITY HOSPITAL OF INDIANA IN340$565.2M12.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $49.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$14.1M+210bp18mo
Cost to Collect4.5%2.5%$13.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$13.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.2M+122bp9mo
Clean Claim Rate88.0%96.0%$430K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$14.1M
Cost to Collect
$13.4M
Denial Rate Reduction
$13.3M
A/R Days Reduction
$8.2M
Clean Claim Rate
$430K
Total EBITDA Uplift$49.4M
Current EBITDA$76.4M
+ RCM Uplift+$49.4M
Pro Forma EBITDA$125.9M
Current Margin11.4%
Pro Forma Margin18.7%
WC Released (1x)$25.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$117.6M$998.8M8.49x53.4%
Base (11x exit)10.0x11.0x$117.6M$1.14B9.67x57.4%
Bull Case9.0x11.0x$105.9M$1.34B12.64x66.1%
Bull (12x exit)9.0x12.0x$105.9M$1.49B14.09x69.7%
Bear Case11.0x10.0x$129.4M$713.3M5.51x40.7%
Bear (11x exit)11.0x11.0x$129.4M$826.7M6.39x44.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 24 hospitals with 173-692 beds
  • Same-state prioritization (n=25)
  • Comp margins: P25=-0.9% / P50=3.8% / P75=9.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.